Yi Wen1, Wilson S Meng1. 1. Division of Pharmaceutical Sciences, Duquesne University, 600, Forbes Avenue, Pittsburgh, PA 15282, USA.
Abstract
Small-interfering RNA (siRNA) is both a powerful tool in research and a promising therapeutic platform to modulate expression of disease-related genes. Malignant tumors are attractive disease targets for nucleic acid-based therapies. siRNA directed against oncogenes, and genes driving metastases or angiogenesis have been evaluated in animal models and in some cases, in humans. The outcomes of these studies indicate that drug delivery is a significant limiting factor. This review provides perspectives on in vivo validated nanoparticle-based siRNA delivery systems. Results of recent advances in liposomes and polymeric and inorganic formulations illustrate the need for mutually optimized attributes for performance in systemic circulation, tumor interstitial space, plasma membrane, and endosomes. Physiochemical properties conducive to efficient siRNA delivery are summarized and directions for future research are discussed.
Small-interfering Rn class="Chemical">NA (siRNA) is both a powerful tool in research and a promising therapeutic platform to modulate expression of disease-related genes. Malignant tumors are attractive disease targets for nucleic acid-based therapies. siRNA directed against oncogenes, and genes driving metastases or angiogenesis have been evaluated in animal models and in some cases, in humans. The outcomes of these studies indicate that drug delivery is a significant limiting factor. This review provides perspectives on in vivo validated nanoparticle-based siRNA delivery systems. Results of recent advances in liposomes and polymeric and inorganic formulations illustrate the need for mutually optimized attributes for performance in systemiccirculation, tumor interstitial space, plasma membrane, and endosomes. Physiochemical properties conducive to efficient siRNA delivery are summarized and directions for future research are discussed.
Authors: Katharina von Gersdorff; Niek N Sanders; Roosmarijn Vandenbroucke; Stefaan C De Smedt; Ernst Wagner; Manfred Ogris Journal: Mol Ther Date: 2006-09-15 Impact factor: 11.454
Authors: Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams Journal: Nat Cell Biol Date: 2003-08-24 Impact factor: 28.824
Authors: Sanjay K Pandey; Thurman M Wheeler; Samantha L Justice; Aneeza Kim; Husam S Younis; Danielle Gattis; Dominic Jauvin; Jack Puymirat; Eric E Swayze; Susan M Freier; C Frank Bennett; Charles A Thornton; A Robert MacLeod Journal: J Pharmacol Exp Ther Date: 2015-09-01 Impact factor: 4.030
Authors: Josimar O Eloy; Raquel Petrilli; Robert W Brueggemeier; Juliana Maldonado Marchetti; Robert J Lee Journal: Anticancer Agents Med Chem Date: 2017 Impact factor: 2.505